ERBB2 and breast cancer: With the advancement of medical treatment, breast cancer treatment technology has been developed to a great extent, not only in terms of drug treatment with trastuzumab, an anti-HER2 target [4], but also in terms of surgery, from extended radical breast cancer surgery to less invasive breast-conserving surgery [5].